Cargando…
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
B7-H4 is a newly identified B7 homolog that plays an important role in maintaining T-cell homeostasis by inhibiting T-cell proliferation and lymphokine-secretion. In this study, we investigated the signal transduction pathways inhibited by B7-H4 engagement in mouse T cells. We found that treatment o...
Autores principales: | Wang, Xiaojie, Hao, Jianqiang, Metzger, Daniel L., Ao, Ziliang, Chen, Lieping, Ou, Dawei, Verchere, C. Bruce, Mui, Alice, Warnock, Garth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251556/ https://www.ncbi.nlm.nih.gov/pubmed/22238573 http://dx.doi.org/10.1371/journal.pone.0028232 |
Ejemplares similares
-
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Improving Islet Engraftment by Gene Therapy
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
por: Wang, Xiaojie, et al.
Publicado: (2012) -
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
por: Cicenas, Jonas, et al.
Publicado: (2017)